Last reviewed · How we verify
Phenprocoumon, Ticagrelor, ASA
Phenprocoumon, Ticagrelor, ASA is a Small molecule drug developed by Medical University of Vienna. It is currently FDA-approved.
Phenprocoumon, Ticagrelor, and ASA (Aspirin) are medications used to treat various conditions, including Acute Coronary Syndrome, Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation, and Antiphospholipid Syndrome. Ticagrelor specifically works as a small molecule negative allosteric modulator of the P2Y purinoceptor 12, a type of purinergic receptor.
At a glance
| Generic name | Phenprocoumon, Ticagrelor, ASA |
|---|---|
| Sponsor | Medical University of Vienna |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
- Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
- Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)
- Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)
- Antithrombotic Triple Therapy in Humans (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phenprocoumon, Ticagrelor, ASA CI brief — competitive landscape report
- Phenprocoumon, Ticagrelor, ASA updates RSS · CI watch RSS
- Medical University of Vienna portfolio CI
Frequently asked questions about Phenprocoumon, Ticagrelor, ASA
What is Phenprocoumon, Ticagrelor, ASA?
Who makes Phenprocoumon, Ticagrelor, ASA?
What development phase is Phenprocoumon, Ticagrelor, ASA in?
Related
- Manufacturer: Medical University of Vienna — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing